News For PRX From The Last 14 Days Check below for free stories on PRX the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2010
|
| 11:17 EDT |  | PRX |
| theflyonthewall.com: | Par Pharmaceutical volatility elevated as shares trend lower | | Par Pharmaceutical is recently down 67c to $24.72. On February 5th PRX announced the FDA stated an inability to approve Zuplenz due to an agency wide restriction on foreign travel to India. PRX is expected to report Q4 EPS on February 24. Call option volume of 609 contracts compares to put volume of 1,146 contracts. February put option implied volatility is at 50, March is at 56 , May is at 51; above its 26-week average of 45, according to Track Data, suggesting larger price movement. :theflyonthewall.com |
|
|
February 5, 2010
|
| 16:48 EDT |  | PRX |
| theflyonthewall.com: | Par subsidiary gets update on Zuplenz new drug application | | Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, announced that the FDA issued a complete response letter regarding the new drug application, or NDA, for Zuplenz oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery. Due to an agency-wide restriction on foreign travel in India, the FDA has been unable to perform an inspection of the clinical and analytical sites for a bioequivalence study, and therefore, cannot approve the application at this time. The FDA advised that they will schedule and perform an inspection of these sites as soon as possible. Strativa will continue to work with the FDA on completing these site inspections and finalization of product labeling. No issues related to the study data or film product were identified. :theflyonthewall.com |
| | 07:19 EDT |  | PRX |
|
|
January 30, 2010
|
| 16:39 EDT |  | PRX |
|
|
|
Subscribe for More Information